Genflow Biosciences (LON:GENF) Announces Quarterly Earnings Results

Genflow Biosciences (LON:GENF) posted its earnings results on Thursday. The company reported GBX (0.33) EPS for the quarter, Digital Look Earnings reports. Genflow Biosciences had a return on equity of 377.33% and a net margin of 840.76%.

Genflow Biosciences Stock Performance

Genflow Biosciences stock traded down GBX 0.03 during midday trading on Thursday, hitting GBX 2.77. 3,763,003 shares of the company were exchanged, compared to its average volume of 2,702,674. The firm has a market capitalization of £14.84 million, a PE ratio of -5.52 and a beta of 2.11. Genflow Biosciences has a fifty-two week low of GBX 0.55 and a fifty-two week high of GBX 3.12. The business has a fifty day simple moving average of GBX 2.04 and a two-hundred day simple moving average of GBX 1.97.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.